about
Gene expression profile of idiopathic thrombocytopenic purpura (ITP).Gene expression and pathway analysis of immune thrombocytopenic purpura.Neonatal alloimmune thrombocytopenia and neutropenia associated with maternal human leukocyte antigen antibodies.Immune thrombocytopenia in children less than 1 year of age: a single-institution 10-year experience.Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.Estimation of liver T₂ in transfusion-related iron overload in patients with weighted least squares T₂ IDEAL.Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease.Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.Central venous catheter complications in sickle cell disease.Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature.Hematologic problems in immigrants from Southeast Asia.Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome.Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis.Pregnancy Complicated by Gorham-Stout Disease and Refractory ChylothoraxEvaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.Erratum: Pregnancy Complicated by Gorham-Stout Disease and Refractory Chylothorax.Idiopathic neutropenia of childhood is associated with Fas/FasL expression.The ASPHO 2015 Distinguished Career Award Goes to Dr. Winfred C. Wang, MD.Summary of symposium: the future of stem cell transplantation for sickle cell disease.Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.Disseminated intravascular coagulation due to IgM-mediated autoimmune hemolytic anemia.Pseudotumor cerebri in two adolescents with acquired aplastic anemia.Resolution of chronic hepatic sequestration in a patient with homozygous sickle cell disease receiving hydroxyurea.Cow's milk allergy in a patient with hyper-IgE syndrome.Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease.Malignant transformation of infantile hemangioma to angiosarcoma: response to chemotherapy with bevacizumab.Cold agglutinin syndrome in pediatric liver transplant recipients.An exploratory epidemiological study of Langerhans cell histiocytosis.Clofarabine in refractory Langerhans cell histiocytosis.Extranodal Rosai-Dorfman disease in childrenDarbepoetin alfa and ferric gluconate ameliorate the anemia associated with recessive dystrophic epidermolysis bullosaNatural history of moderate aplastic anemia in childrenClofarabine salvage therapy for refractory high-risk langerhans cell histiocytosisLangerhans Cell Histiocytosis of the Gastrointestinal Tract: Evidence for Risk Organ StatusAltered cerebral perfusion in children with Langerhans cell histiocytosis after chemotherapy
P50
Q33372416-C9E8EB24-48AD-4F86-BCF8-FF90E4BC2862Q33377373-389D9F7C-AFF4-4558-AE63-C7328598E827Q33383364-E3983335-F332-4F3A-AED8-8CD800CB24C8Q33402174-68D6613D-0858-44E5-92A9-076593A35DC4Q33410429-FAF18116-DD5A-4839-9BF3-62F20F74B632Q33901119-9CA0E0A1-C903-40E3-A3BF-59C8FDB0C830Q34152447-369FC3DF-6483-4380-8C2E-0529D8E85770Q34187958-8EEB07B2-B8B8-488C-806D-CCB0B7D3A4ACQ34522368-57E5B149-C5D2-4783-886A-375BA2E3B169Q35743427-480E7D03-279A-4568-B1B7-5FCDE7CADBF9Q35910738-807A0940-4417-4273-906E-5DC0F70D93F7Q35931495-1C80CEF4-1E84-400E-A592-1B5F36596C3AQ36063149-4BE86305-0741-4364-BD63-BC1132CF97A2Q36541732-3CC0E841-0E6B-4389-BEFF-BCC863F35614Q37309814-36059785-B2E5-418A-A0E2-70EE33A72C80Q40180517-A825369B-1976-4E31-B577-B81038F93AEFQ42373636-16B70BCF-D76F-4623-97A7-D8C757DCD34DQ42873718-1732CC2D-1F3B-4A53-A1DA-5BBA87F692FFQ43549284-8AFAF5BB-5420-442B-A704-CE37456E7BD3Q43681988-3B67F94E-D869-4B5E-904E-66D5F2515873Q43916589-EF4E2AF5-3FA4-4B92-8EBB-A1BF072AB135Q44188565-69B59800-3360-4AD4-A0CE-39F2042BF6F1Q44240581-C17EF33A-654D-4DB5-9549-09A9712FBD50Q44351009-D18F57A8-BC58-4AD2-BE47-A305092940A8Q44855682-4C3A1515-22A8-4F29-91A3-9B7F9297F09DQ46025654-A8D45707-A2FA-4A3C-A774-3FD974B7C8A2Q46061982-C4820F86-63B8-47B4-AA7D-4462D27011CBQ46077192-5D5D2FC8-CF87-4A06-AB17-A96B0C04EF86Q46137147-C22F6B79-E1D0-4AE8-B3E2-2D807244AAF6Q46486213-E0697DD4-45AE-4371-AC77-273B4D033B6FQ75225339-44D21B9A-7D39-44A2-8BD1-F0DE5B768466Q79419980-D30049C0-52D4-48B2-BCDA-8145684D8F67Q80594754-73761E58-3E88-4079-82CE-2B375166635EQ85746021-6BC0790C-F000-4857-B6B5-03808815D6B0Q91675458-070884EB-552A-4C0B-BA9B-90F0C15370E3Q91703645-25EA8CCB-0945-4211-A620-6D4ACC122AA9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael Jeng
@ast
Michael Jeng
@en
Michael Jeng
@es
Michael Jeng
@nl
Michael Jeng
@sl
type
label
Michael Jeng
@ast
Michael Jeng
@en
Michael Jeng
@es
Michael Jeng
@nl
Michael Jeng
@sl
prefLabel
Michael Jeng
@ast
Michael Jeng
@en
Michael Jeng
@es
Michael Jeng
@nl
Michael Jeng
@sl
P106
P21
P31
P496
0000-0001-8200-8484